Foshan United Medical Technologies
Revolutionizing Wound Care with High-Quality Materials

Historically, keeping a wound dry was considered the quickest way to heal chronic wounds. However, with decades of research and studies and endless effort by the industry, a moist wound healing theory and system have been established over the last 30 years. This requires wound dressings to absorb the exudates and provide a moist environment to achieve optimum healing effects.

Taking advantage of this new theory,Foshan United Medical Technologies Ltd. (UMT), a prominent technology company specializing in designing and manufacturing advanced wound care products for acute and chronic injuries, has become the vanguard of recently emerged manufacturers of advanced wound care products. UMT achieved this by improving the standards of wound care products and pursuing better product performance through innovations.

Driven by managing director Dr. Xiaodong Wang’s 30- plus years of experience in research and development, manufacturing management, quality control, compliance, and customer service, the firm has become an industry leader with a solid foundation for success.

UMT’s wound care prowess is powered by its emphasis on using high-quality materials to build products of exceptional quality and impeccable regulatory compliance. One of the company’s competencies is the fibrous materials—alginate, chitosan, and carboxymethyl cellulose (CMC), which serve as the basis for delivering outstanding results.

Alginate, derived from seaweed, is renowned for its exceptional absorbency properties. UMT has brought alginate wound dressings to a higher standard with significant fluid handling capability that enables efficient absorption and creates a moist healing environment for chronic wounds. Similarly, the company’s CMC-driven products possess exceptional absorbency and form a soft gel upon contact with wound fluid or water. This unique material promotes gentle and effective moisture absorption for a favorable healing environment.

UMT has also developed a patented chitosan wound dressing that overcomes chitosan’s conventional limitations and modifies the material’s absorbency and bacteriostatic properties, delivering a unique and effective way to stop bleeding and promote healing. These attributes are particularly beneficial for wound care, as bleeding and infection risks are expected when the skin is compromised.

These development works have led UMT to become the leading company in the development and commercialization of CMC gelling dressing. Also, UMT is the first company with CE-marked chitosan for chronic wound management. UMT is also the first Chinese company to complete the CE marking of a silver alginate wound dressing, a product needed in clinical to combat wound infections.

UMT’s deep understanding of fibrous materials and unwavering focus on research, quality, and regulatory compliance are at the heart of these competencies. It has earned a reliable reputation in the wound care industry, where it collaborates with clients from concept development and design to manufacturing and global distribution.

“We build strong relationships with customers, understanding their needs, analyzing industry trends, and providing innovative solutions. Our proactive approach sets us apart and ensures we deliver exactly what our customers want,” says Dr. Wang.

The ability in innovation and compliance with European and US regulations is the core of our competence and will remain the focus of our company. We strive to provide a better customer service by meeting their requirements from design and manufacture to distribution.

Recently, UMT has introduced a revolutionary wound closure device specifically designed to facilitate the closure of minor cuts without requiring invasive procedures like sutures or staples, which can be painful and leave scars upon removal. By applying this device to the wound and gently pulling, users can effectively close the wound without discomfort.

Primarily used for surgical wounds resulting from minor operations or small cuts, the wound closure device has gained popularity in the Asian, European, and American markets. Above all, it offers a non-invasive solution for managing chronic wounds, improving patient outcomes, and promoting proper healing while preventing complications.

Driven by a well-structured organization and a capable team, UMT ensures efficient communication, project management, and strong customer relationships, acting as a trusted partner in the wound care industry.

“The ability to innovate and comply with European and US regulations is the core of our competence and will remain the focus of our company. We strive to provide a better customer service by meeting their requirements from design and manufacture to distribution,” concludes Dr. Wang.